Abstract
Patients with respiratory distress present to the Emergency Department (ED) primarily due to hypoxia, hypoxemia and hypercapnea. These critically ill patients are commonly managed using non-invasive ventilation therapy (NIV), which is comprised of Continuous Positive Airway Pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP). In our organization, patients requiring NIV therapy are admitted to the intensive care unit (ICU) or step-down area because of frequent monitoring. In addition, CPAP and BiPAP are considered ventilators, which require orders from providers who are credentialed with ventilator privileges. In analyzing the cost effectiveness of NIV therapy through retrospective chart review, it was identified that there were total of 94 ED patients placed on NIV, who were admitted to ICU in CY2017. The higher level of care was necessitated because of the need for a provider with ventilator privileges. This led the respiratory therapy (RT) and ED nursing teams to implement the use of high-flow nasal cannula therapy that addresses hypoxemia and hypercapnea as effectively as CPAP and BiPAP, but does not require ventilator-privileged provider orders. The purpose of this study is to examine the effect of implementing high-flow nasal cannula therapy on ICU admission of adult patients presenting in ED with respiratory distress/failure.
Sigma Membership
Non-member
Lead Author Affiliation
Rush Copley Medical Center, Aurora, Illinois, USA
Type
Poster
Format Type
Text-based Document
Study Design/Type
Descriptive/Correlational
Research Approach
Pilot/Exploratory Study
Keywords:
Emergency Care, Respiratory Therapy, Treating Respiratory Distress
Recommended Citation
Lugod, Maureen; Karales, Ruth; and Keller, Lisa, "Implementing high-flow nasal cannula therapy in the emergency department" (2020). General Submissions: Presenations (Oral and Poster). 95.
https://www.sigmarepository.org/gen_sub_presentations/2020/posters/95
Conference Name
Emergency Nursing 2020
Conference Host
Emergency Nurses Association
Conference Location
Virtual Event
Conference Year
2020
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Review Type
Abstract Review Only: Reviewed by Event Host
Acquisition
Proxy-submission
Implementing high-flow nasal cannula therapy in the emergency department
Virtual Event
Patients with respiratory distress present to the Emergency Department (ED) primarily due to hypoxia, hypoxemia and hypercapnea. These critically ill patients are commonly managed using non-invasive ventilation therapy (NIV), which is comprised of Continuous Positive Airway Pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP). In our organization, patients requiring NIV therapy are admitted to the intensive care unit (ICU) or step-down area because of frequent monitoring. In addition, CPAP and BiPAP are considered ventilators, which require orders from providers who are credentialed with ventilator privileges. In analyzing the cost effectiveness of NIV therapy through retrospective chart review, it was identified that there were total of 94 ED patients placed on NIV, who were admitted to ICU in CY2017. The higher level of care was necessitated because of the need for a provider with ventilator privileges. This led the respiratory therapy (RT) and ED nursing teams to implement the use of high-flow nasal cannula therapy that addresses hypoxemia and hypercapnea as effectively as CPAP and BiPAP, but does not require ventilator-privileged provider orders. The purpose of this study is to examine the effect of implementing high-flow nasal cannula therapy on ICU admission of adult patients presenting in ED with respiratory distress/failure.